Cargando…
Timing for intracoronary administration of bone marrow mononuclear cells after acute ST-elevation myocardial infarction: a pilot study
INTRODUCTION: Most studies on intracoronary bone marrow mononuclear cell transplantation for acute myocardial infarction involve treatment 3–7 days after primary percutaneous coronary intervention (PCI); however, the optimal timing is unknown. The present study assessed the therapeutic effect at dif...
Autores principales: | Huang, Rongchong, Yao, Kang, Sun, Aijun, Qian, Juying, Ge, Lei, Zhang, Yiqi, Niu, Yuhong, Wang, Keqiang, Zou, Yunzeng, Ge, Junbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509778/ https://www.ncbi.nlm.nih.gov/pubmed/26021558 http://dx.doi.org/10.1186/s13287-015-0102-5 |
Ejemplares similares
-
The diagonal branches and outcomes in patients with anterior ST- elevation myocardial infarction
por: Zhang, Shuning, et al.
Publicado: (2020) -
Infarcted myocardium-like stiffness contributes to endothelial progenitor lineage commitment of bone marrow mononuclear cells
por: Zhang, Shuning, et al.
Publicado: (2011) -
The Usefulness of Intracoronary Imaging in Patients with ST-Segment Elevation Myocardial Infarction
por: Karamasis, Grigoris V., et al.
Publicado: (2023) -
Efficacy and Safety of Thrombectomy Combined with Intracoronary Administration of Tirofiban in ST-segment Elevation Myocardial Infarction (STEMI)
por: Gao, Lu, et al.
Publicado: (2016) -
Utilization of an Optimized Radiation Strategy in Primary Percutaneous Coronary Intervention for Patients with ST-Segment-Elevation Myocardial Infarction
por: Zhong, Xin, et al.
Publicado: (2019)